Series B underwriters don't buy growth. They buy efficiency.
At Series B, the question shifts. It's no longer "can you grow?" — it's "can you grow efficiently, retain the revenue you win, and expand what you have?" Opagio builds the efficiency narrative on the intangible infrastructure that makes it real: customer capital, data moat, ops layer, pricing architecture.
You recognise the new bar
Three numbers tell the story. None of them are revenue growth.
- Magic number 0.9. Burn multiple 2.2. A year ago those read as acceptable. Today the partner meeting is a polite grilling on exactly those ratios.
- CAC payback is lengthening. You suspect it's a mix issue, not a unit-economics issue — but you cannot yet show it at segment or cohort level.
- NRR 108% is no longer enough. The category leader is at 128%. Partners are asking for the expansion story and you don't yet have the pricing or retention architecture to answer.
What the diagnostic maps
- An efficiency read grounded in the Opagio 12. Which drivers are producing the expansion, where retention risk concentrates, which segments underwrite the next 24 months.
- Unit economics, restated. Cohort-and-segment denominators replace blended averages — with pricing and packaging recommendations that recompound by Q3.
- A Series B narrative stack. Category case, efficiency case, moat case, operating case — each anchored to measurable intangible assets, not anecdote.
Rule of 40 medians for Series B have shifted from 40% into the mid-to-high 40s since 2024. The efficiency bar has moved — and the narrative has to move with it.
Sources: Bessemer State of the Cloud 2024; Battery OpenCloud 2024.
The Bottom Line
Series B is priced on durable efficiency, not headline growth. The companion pages unpack the specifics: the 2025 efficiency bar and why it moved, and the 18–24 month playbook to move NRR from 108% to 128%. The diagnostic tells you where the binding constraint sits.
Stop selling growth. Start selling efficiency.
12 drivers. 8 minutes. The shape of the efficiency narrative your Series B lead will price against.